Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV.
作者信息
Jiang Rui, Sun Jianjun, Zhao Bihe, Zhang Renfang, Liu Li, Chen Jun
机构信息
Department of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
出版信息
AIDS. 2023 Jul 1;37(8):1341-1342. doi: 10.1097/QAD.0000000000003564.
Abstract
摘要
相似文献
1
Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV.艾滋病毒感染者短期服用阿兹夫定治疗新冠肺炎后出现M184I突变。
AIDS. 2023 Jul 1;37(8):1341-1342. doi: 10.1097/QAD.0000000000003564.
2
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.阿兹夫定是一种新型核苷类逆转录酶抑制剂，在体外显示出良好的药物联合特性，且对耐药菌株的抑制作用优于拉米夫定。
PLoS One. 2014 Aug 21;9(8):e105617. doi: 10.1371/journal.pone.0105617. eCollection 2014.
3
Pre-exposure Prophylaxis Use History in People With Antiretroviral Resistance at HIV Diagnosis: Findings From New York City HIV Surveillance and Partner Services, 2015-2022.艾滋病毒诊断时具有抗逆转录病毒耐药性者的暴露前预防用药史：来自纽约市艾滋病毒监测和伙伴服务的发现，2015-2022 年。
Clin Infect Dis. 2024 May 15;78(5):1240-1245. doi: 10.1093/cid/ciad699.
4
An efficient tool for surveying CRF01_AE HIV type 1 resistance in Thailand to combined stavudine-lamivudine-nevirapine treatment: mutagenically separated PCR targeting M184I/V.
AIDS Res Hum Retroviruses. 2007 Dec;23(12):1461-8. doi: 10.1089/aid.2007.0042.
5
Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study.中国新疆住院 COVID-19 患者中阿兹夫定对重症结局的疗效：一项单中心、回顾性、匹配队列研究。
Expert Rev Anti Infect Ther. 2024 Jul;22(7):569-577. doi: 10.1080/14787210.2024.2362900. Epub 2024 Jun 27.
6
Presence of M184I/V in minor HIV-1 populations of patients with lamivudine and/or didanosine treatment failure.在拉米夫定和/或去羟肌苷治疗失败的患者的少量HIV-1群体中存在M184I/V。
HIV Med. 2007 Nov;8(8):504-10. doi: 10.1111/j.1468-1293.2007.00502.x.
7
M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA.HIV 逆转录酶中的 M184I/V 取代和 E138K/M184I/V 双取代不会显著影响 EFdA 的抗病毒活性。
J Antimicrob Chemother. 2017 Nov 1;72(11):3008-3011. doi: 10.1093/jac/dkx280.
8
People Living with HIV in the COVID-19 Era: A Case Report.新冠疫情时代的艾滋病病毒感染者：一例病例报告。
AIDS Res Hum Retroviruses. 2021 Apr;37(4):253-254. doi: 10.1089/AID.2020.0149. Epub 2020 Sep 18.
9
Anxiety and Worry About COVID-19 Infection are Associated with Less Confidence in Ability to Engage in Treatment: Results from a South India Cohort of People Living with HIV (PLWH).对感染新冠病毒的焦虑和担忧与参与治疗的能力信心较低有关：来自印度南部艾滋病毒感染者队列的结果。
J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221080303. doi: 10.1177/23259582221080303.
10
Interaction of reverse transcriptase (RT) mutations conferring resistance to lamivudine and etravirine: effects on fitness and RT activity of human immunodeficiency virus type 1.逆转录酶（RT）突变体与拉米夫定和依曲韦林耐药性的相互作用：对人类免疫缺陷病毒 1 型的适应性和 RT 活性的影响。
J Virol. 2011 Nov;85(21):11309-14. doi: 10.1128/JVI.05578-11. Epub 2011 Aug 17.
引用本文的文献
1
Mechanism and spectrum of inhibition of viral polymerases by 2'-deoxy-2'-β-fluoro-4'-azidocytidine or azvudine.2'-脱氧-2'-β-氟-4'-叠氮胞苷或阿兹夫定对病毒聚合酶的抑制机制及谱
NAR Mol Med. 2025 Aug 11;2(3):ugaf029. doi: 10.1093/narmme/ugaf029. eCollection 2025 Jul.
2
Systematic evaluation of therapeutic effectiveness of Azvudine in treating COVID-19 hospitalized patients: a retrospective cohort study.阿兹夫定治疗 COVID-19 住院患者疗效的系统评价：一项回顾性队列研究。
Front Cell Infect Microbiol. 2024 Nov 7;14:1453234. doi: 10.3389/fcimb.2024.1453234. eCollection 2024.
本文引用的文献
1
Small molecules in the treatment of COVID-19.小分子药物治疗 COVID-19。
Signal Transduct Target Ther. 2022 Dec 5;7(1):387. doi: 10.1038/s41392-022-01249-8.
2
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients.阿兹夫定是一种归巢至胸腺的抗新型冠状病毒药物，对治疗新冠肺炎患者有效。
Signal Transduct Target Ther. 2021 Dec 6;6(1):414. doi: 10.1038/s41392-021-00835-6.
3
Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study.中国广东地区未经治疗的 HIV-1 患者中的传播耐药和传播簇：一项横断面研究。
Virol J. 2021 Sep 6;18(1):181. doi: 10.1186/s12985-021-01653-6.
4
HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014-2019.2014 - 2019年华南男男性行为者抗逆转录病毒治疗失败人群中的HIV-1耐药性与基因传播网络
Infect Drug Resist. 2021 Aug 4;14:2977-2989. doi: 10.2147/IDR.S317187. eCollection 2021.
5
Mechanistic Insight into Antiretroviral Potency of 2'-Deoxy-2'-β-fluoro-4'-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention.机制洞察 2'-脱氧-2'-β-氟-4'-叠氮胞苷（FNC）抗逆转录病毒效力及其对 HIV-1 预防的长效作用。
J Med Chem. 2020 Aug 13;63(15):8554-8566. doi: 10.1021/acs.jmedchem.0c00940. Epub 2020 Aug 3.
6
Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.中国上海新诊断 HIV 感染患者中 HIV-1 基因型的多样性和治疗前耐药率高。
BMC Infect Dis. 2019 Apr 8;19(1):313. doi: 10.1186/s12879-019-3927-1.
7
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.阿兹夫定是一种新型核苷类逆转录酶抑制剂，在体外显示出良好的药物联合特性，且对耐药菌株的抑制作用优于拉米夫定。
PLoS One. 2014 Aug 21;9(8):e105617. doi: 10.1371/journal.pone.0105617. eCollection 2014.
8
Quantification of 2'-deoxy-2'-β-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies.使用液相色谱-四极杆飞行时间质谱和液相色谱-三重四极杆质谱法对大鼠和犬血浆中的2'-脱氧-2'-β-氟-4'-叠氮胞苷进行定量分析：在生物利用度和药代动力学研究中的应用
J Pharm Biomed Anal. 2014 Sep;98:379-86. doi: 10.1016/j.jpba.2014.06.019. Epub 2014 Jun 20.
9
Synthesis of new 2'-deoxy-2'-fluoro-4'-azido nucleoside analogues as potent anti-HIV agents.合成新型 2'-脱氧-2'-氟-4'-叠氮核苷类似物作为有效的抗 HIV 药物。
Eur J Med Chem. 2011 Sep;46(9):4178-83. doi: 10.1016/j.ejmech.2011.06.020. Epub 2011 Jun 23.
10
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance.HIV逆转录酶M184I/V突变与单个胸苷类似物突变联合对核苷类逆转录酶抑制剂耐药性的表型影响
AIDS. 2004 Aug 20;18(12):1691-6. doi: 10.1097/01.aids.0000131355.44834.e4.
Zotero 插件